510(k) device
ATLAAS (Atraumatic Left Atrial Appendage System) (AD)
Genesee Biomedical, Inc. · Left Atrial Appendage Clip, Implantable (PZX, Class II) · First FDA decision May 22, 2026, newest May 22, 2026Atrial fibrillationStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "ATLAAS"
MAUDE reports
0
Brand "ATLAAS", since 2015
PubMed studies
3
Mentioning "ATLAAS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ATLAAS (Atraumatic Left Atrial Appendage System) (AD)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K252917 · Decided May 22, 2026 · 252 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "ATLAAS", any status and sponsor, newest update first.
No registered device study names "ATLAAS".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ATLAAS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PZX
145 reports: 50 malfunction, 87 injury, 7 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ATLAAS"[tiab]. The summary above synthesizes these.
- Head and neck target delineation using a novel PET automatic segmentation algorithm.
Berthon B, Evans M, Marshall C, et al. · Radiother Oncol · 2017
- Machine-learned target volume delineation of 18F-FDG PET images after one cycle of induction chemotherapy.
Parkinson C, Evans M, Guerrero-Urbano T, et al. · Phys Med · 2019Clinical Trial, Phase I
- ATLAAS: an automatic decision tree-based learning algorithm for advanced image segmentation in positron emission tomography.
Berthon B, Marshall C, Evans M, et al. · Phys Med Biol · 2016
Other devices of this type
Also filed under product code PZX.
- AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0)AtriCure, Inc. · 510(k) 2023
- LAA Exclusion SystemSyntheon, LLC · 510(k) 2023
- ACHM30 AtriClip FLEX-Mini LAA Exclusion SystemAtriCure, Inc. · 510(k) 2026
- ECLIPTIS Left Atrial Appendage Exclusion System (ECS135)Edwards Lifesciences · 510(k) 2026
- AtriClip PRO-Mini LAA Exclusion System (PROM)AtriCure, Inc. · 510(k) 2025
- AtriClip FLEX-Mini LAA Exclusion System (ACHM)AtriCure, Inc. · 510(k) 2024
- ArtiClip LAA Exclusion SystemAtriCure, Inc. · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.